Pillar A M, Prince A K, Atterwill C K
Department of Pharmacology, King's College (KQC), Strand, London, U.K.
Toxicology. 1988 Apr;49(1):115-9. doi: 10.1016/0300-483x(88)90182-5.
The cholinergic neurotoxin ECMA causes a biphasic loss of choline acetyltransferase activity in foetal rat whole brain reaggregate cultures. Initial direct inhibition is followed by longer-term loss of cholinergic neurones. Final muscarinic receptor binding, neurofilament protein and Na+, K+-ATPase concentrations suggest that the lesion is specific for cholinergic neurones at 12.5 microM ECMA, but is more generalised at 50 microM ECMA.